|
|
|
|
|
Legal status
Patent revoked (after opposition at EPO)
| (51) | INT.CL. | A61K 31/485 | (2006.01) |
| A61K 9/19 | (2006.01) | ||
| A61K 31/047 | (2006.01) | ||
| A61K 31/195 | (2006.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61K 47/12 | (2006.01) | ||
| A61K 47/18 | (2006.01) |
| (11) | Number of the document | 2368554 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10184684.8 |
| Date of filing the European patent application | 2004-04-08 | |
| (97) | Date of publication of the European application | 2011-09-28 |
| (45) | Date of publication and mention of the grant of the patent | 2014-12-24 |
| (46) | Date of publication of the claims translation | 2015-05-25 |
| (30) | Number | Date | Country code |
| 461611 P | 2003-04-08 | US |
| (72) |
Sanghvi, Suketu, US
Boyd, Thomas, US
|
| (73) |
Progenics Pharmaceuticals, Inc.,
777 Old Saw Mill River Road, Tarrytown, NY 10591,
US
|
| (74) |
Liucija JANICKAITĖ,
Inpatra UAB, Šeškinės g. 59-53, LT-07162 Vilnius,
LT
|
| (54) | Metilnaltreksono turinčios farmacinės kompozicijos |
| Pharmaceutical formulations containing methylnaltrexone |
| Payment date | Validity (years) | Amount | |
| 2020-04-07 | 17 | 347.00 EUR |
| Patent revoked (after opposition at EPO) | ||
| Invalidation date | 2020-11-13 |